(Q72997755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586303%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

0 references

1 reference

title

Rating fibrosis progression in chronic liver diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586303%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

main subject

chronic liver disease

0 references

author

William Rosenberg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586303%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586303%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586303%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586303%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586303%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

357-360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586303%20AND%20SRC:MED&resulttype=core&format=json

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Reversal of “Cirrhosis” in Idiopathic Haemochromatosis Following Long-term Intensive Venesection Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Reversibility of hepatic fibrosis in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Use of corticosteroid therapy in autoimmune hepatitis resulting in the resolution of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

A comparison of fibrosis progression in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900010-2

7 January 2021

10.1016/S0168-8278(03)00010-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586303%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference